Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Martin

Showing results (121-130 of 216) with videos related to

Pageof 22
Sort By:
Science Translational Medicine|September 25, 2015
JC polyomavirus mutants escape antibody-mediated neutralizationUpasana Ray, Paola Cinque, Simonetta Gerevini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 4, 2012
TCR bias and HLA cross-restriction are strategies of human brain-infiltrating JC virus-specific CD4+ T cells during viral infectionSara Yousef, Raquel Planas, Karima Chakroun, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 6, 2024
Clinical and Immunologic Effects of Paraprobiotics in Long-COVID Patients: A Pilot StudyMaría José Docampo, Mattei Batruch, Pietro Oldrati, et al.
Frontiers in Immunology|September 11, 2024
Enhanced and cross-reactive <i>in vitro</i> memory B cell response against Epstein-Barr virus nuclear antigen 1 in multiple sclerosisZoe Marti, Josefine Ruder, Olivia G Thomas, et al.
The Lancet. Neurology|September 22, 2006
Infectious causes of multiple sclerosisGavin Giovannoni, Gary R Cutter, Jan Lunemann, et al.
Annals of Clinical and Translational Neurology|September 25, 2015
Central role of Th2/Tc2 lymphocytes in pattern II multiple sclerosis lesionsRaquel Planas, Imke Metz, Yaneth Ortiz, et al.
European Journal of Immunology|April 17, 2008
Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: implications for the initiation of the autoimmune response in multiple sclerosisXin Zhang, Yunan Tang, Danuta Sujkowska, et al.
Clinical Neuropharmacology|February 10, 2012
Sustained efficacy of natalizumab in the treatment of relapsing-remitting multiple sclerosis independent of disease activity and disability at baseline: real-life data from a Swiss cohortUlf Kallweit, Ilijas Jelcic, Nathalie Braun, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 25, 2009
Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood--brain barrier disruption in multiple sclerosisBibiana Bielekova, Nancy Richert, Thomas Howard, et al.
Annals of Clinical and Translational Neurology|August 28, 2020
Neurological manifestations of coronavirus infections - a systematic reviewJesper Almqvist, Tobias Granberg, Antonios Tzortzakakis, et al.
Pageof 22

Showing results (121-130 of 216) with videos related to

Sort By:
Pageof 22
Science Translational Medicine|September 25, 2015
JC polyomavirus mutants escape antibody-mediated neutralizationUpasana Ray, Paola Cinque, Simonetta Gerevini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 4, 2012
TCR bias and HLA cross-restriction are strategies of human brain-infiltrating JC virus-specific CD4+ T cells during viral infectionSara Yousef, Raquel Planas, Karima Chakroun, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 6, 2024
Clinical and Immunologic Effects of Paraprobiotics in Long-COVID Patients: A Pilot StudyMaría José Docampo, Mattei Batruch, Pietro Oldrati, et al.
Frontiers in Immunology|September 11, 2024
Enhanced and cross-reactive <i>in vitro</i> memory B cell response against Epstein-Barr virus nuclear antigen 1 in multiple sclerosisZoe Marti, Josefine Ruder, Olivia G Thomas, et al.
The Lancet. Neurology|September 22, 2006
Infectious causes of multiple sclerosisGavin Giovannoni, Gary R Cutter, Jan Lunemann, et al.
Annals of Clinical and Translational Neurology|September 25, 2015
Central role of Th2/Tc2 lymphocytes in pattern II multiple sclerosis lesionsRaquel Planas, Imke Metz, Yaneth Ortiz, et al.
European Journal of Immunology|April 17, 2008
Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: implications for the initiation of the autoimmune response in multiple sclerosisXin Zhang, Yunan Tang, Danuta Sujkowska, et al.
Clinical Neuropharmacology|February 10, 2012
Sustained efficacy of natalizumab in the treatment of relapsing-remitting multiple sclerosis independent of disease activity and disability at baseline: real-life data from a Swiss cohortUlf Kallweit, Ilijas Jelcic, Nathalie Braun, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 25, 2009
Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood--brain barrier disruption in multiple sclerosisBibiana Bielekova, Nancy Richert, Thomas Howard, et al.
Annals of Clinical and Translational Neurology|August 28, 2020
Neurological manifestations of coronavirus infections - a systematic reviewJesper Almqvist, Tobias Granberg, Antonios Tzortzakakis, et al.
Pageof 22